CY1117230T1 - COMPOSITIONS FOR IMMUNIZATION AGAINST STAPHYLOCOCCUS AUREUS - Google Patents

COMPOSITIONS FOR IMMUNIZATION AGAINST STAPHYLOCOCCUS AUREUS

Info

Publication number
CY1117230T1
CY1117230T1 CY20161100193T CY161100193T CY1117230T1 CY 1117230 T1 CY1117230 T1 CY 1117230T1 CY 20161100193 T CY20161100193 T CY 20161100193T CY 161100193 T CY161100193 T CY 161100193T CY 1117230 T1 CY1117230 T1 CY 1117230T1
Authority
CY
Cyprus
Prior art keywords
staphylococcus aureus
compositions
immunization against
against staphylococcus
aureus
Prior art date
Application number
CY20161100193T
Other languages
Greek (el)
Inventor
Fabio Bagnoli
Massimiliano Biagini
Luigi Fiaschi
Guido Grandi
Ravi Mishra
Nathalie Norais
Maria Scarselli
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP12175868.4A external-priority patent/EP2510947B1/en
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of CY1117230T1 publication Critical patent/CY1117230T1/en

Links

Abstract

Ένα αποτελεσματικό εμβόλιο Staphylococcus aureus μπορεί να απαιτεί διάφορα αντιγονικά συστατικά, και έτσι πιστοποιούνται διάφοροι συνδυασμοί αντιγόνων S.aureus για χρήση σε ανοσοποίηση. Αυτά τα πολυπεπτίδια μπορεί προαιρετικώς να χρησιμοποιηθούν σε συνδυασμό με σακχαρίδια S.aureus.An effective Staphylococcus aureus vaccine may require various antigenic components, thus identifying various combinations of S.aureus antigens for use in immunization. These polypeptides may optionally be used in combination with S. aureus saccharides.

CY20161100193T 2009-04-14 2016-03-07 COMPOSITIONS FOR IMMUNIZATION AGAINST STAPHYLOCOCCUS AUREUS CY1117230T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21270509A 2009-04-14 2009-04-14
US23407909A 2009-08-14 2009-08-14
EP12175868.4A EP2510947B1 (en) 2009-04-14 2010-04-14 Compositions for immunising against Staphylococcus aureus

Publications (1)

Publication Number Publication Date
CY1117230T1 true CY1117230T1 (en) 2017-04-05

Family

ID=58487098

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100193T CY1117230T1 (en) 2009-04-14 2016-03-07 COMPOSITIONS FOR IMMUNIZATION AGAINST STAPHYLOCOCCUS AUREUS

Country Status (1)

Country Link
CY (1) CY1117230T1 (en)

Similar Documents

Publication Publication Date Title
BRPI1013780A2 (en) compositions for immunization against staphylococcus aureus.
CY1121389T1 (en) ANTIBODIES SPECIFICALLY BINDED TO TOY STAPHYLOCOCCUS AUREUS A-TOXIN AND METHODS OF USE
CY1117689T1 (en) COMPOSITIONS CONTAINING PULMONARY ANTIGENS
UY37278A (en) ANTI-B7-H3 ANTIBODIES AND DRUG AND ANTIBODY CONJUGATES
PE20150646A1 (en) METHODS OF TREATING A TAUOPATHY
CO6450665A2 (en) ANTI-FGFR3 ANTIBODIES AND METHODS THAT USE THEM
CY1118250T1 (en) CERTAIN TRIAZOLOPYRAZINS, THEIR COMPOSITIONS AND METHODS FOR USE
CR20120310A (en) NEUTRALIZING ANTIBODIES AGAINST THE PROLACTIN RECEPTOR AND THERAPEUTIC USE
CY1117331T1 (en) ACCESSORIES IN ACCESSIBILITY 4 OUTSIDE AUTOMATIC CSF1R AND THEIR USE
CY1121742T1 (en) S100A4 ANTIBODIES AND THERAPEUTIC USES THEREOF
CY1113738T1 (en) Vaccines Against Low-Influenza Influenza In Additives
CU20170169A7 (en) FACTOR ANTIBODIES XI
BR112015010436A2 (en) ANTI-NOTCH3 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
EA201991715A1 (en) COMPOSITIONS CONTAINING AN ANTIBODY TO PDL1
CY1116488T1 (en) ANTI-PERPETIN antibodies
EA201591465A1 (en) SPECIFIC PLOTS FOR MODIFICATION OF ANTIBODIES FOR OBTAINING IMMUNOCONJUGATES
CO6321189A2 (en) BENCEN-SULFONAMIDE TIAZOL AND OXAZOL COMPOUNDS
CU20110029A7 (en) COMPOSITIONS AND METHODS FOR ANTIBODIES DIRECTING TO COMPLEMENT PROTEIN C5
EA201100268A1 (en) VACCINE
BR112015030356A2 (en) methods of treatment of a taupathy
CL2019000019A1 (en) Antibodies with low immunogenicity and use thereof
CR20130632A (en) THE NEUTRALIZING ANTIBODY OF THE MAT3 PROLACTIN RECEIVER AND ITS THERAPEUTIC USE
CY1119912T1 (en) PSEUDOMONAS ANTIGENS AND ANTIGON COMBINATIONS
CY1119873T1 (en) IMPROVED VACCINE DIAGNOSTICS
WO2014152355A3 (en) Osteosarcoma-associated risk markers and uses thereof